Valdes-Socin Hernán, Salvi Roberto, Daly Adrian F, Gaillard Rolf C, Quatresooz Pascale, Tebeu Pierre-Marie, Pralong François P, Beckers Albert
Department of Endocrinology, Centre Hospitalier Universitaire de Liège, Domaine du Sart-Tilman, Liege, Belgium.
N Engl J Med. 2004 Dec 16;351(25):2619-25. doi: 10.1056/NEJMoa040326.
A 30-year-old man who presented with delayed puberty and infertility was found to have hypogonadism associated with an absence of circulating luteinizing hormone. The patient had a homozygous missense mutation in the gene that encodes the beta subunit of luteinizing hormone (Gly36Asp), a mutation that disrupted a vital cystine knot motif and abrogated the heterodimerization and secretion of luteinizing hormone. Treatment with human chorionic gonadotropin increased circulating testosterone, promoted virilization, and was associated with the appearance of normal spermatozoa in low concentrations. This case illustrates the important physiological role that luteinizing hormone plays in male sexual maturation and fertility.
一名30岁男性因青春期发育延迟和不育前来就诊,检查发现其性腺功能减退,同时缺乏循环促黄体生成素。该患者在编码促黄体生成素β亚基的基因中存在纯合错义突变(Gly36Asp),该突变破坏了一个至关重要的胱氨酸结基序,消除了促黄体生成素的异源二聚化和分泌。用人绒毛膜促性腺激素治疗可增加循环睾酮水平,促进男性化,并使低浓度的正常精子出现。该病例说明了促黄体生成素在男性性成熟和生育中所起的重要生理作用。